REVELATION BIOSCIENCES, INC.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

REVB

organization

Jurisdiction: US-DELegal Form: XTIQ

ACTIVE

LEI: 549300UKS15BEXENY615SIC: 2834

Also known as: REVELATION BIOSCIENCES, INC.

SEC Insider

$16.8M

58 transactions

Summary

REVELATION BIOSCIENCES, INC. (REVB) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $432KSales: $6.8M19 insiders

Date	Insider	Type	Value
2025-10-29	Zygmont Chester Stanley III(Chief Financial Officer)	A	$500K
2025-10-29	Rolke James(Chief Executive Officer)	A	$500K
2026-01-08	Rolke James(Chief Executive Officer)	A	$480K
2025-02-11	Rolke James(Chief Executive Officer)	A	$116K
2026-01-08	Zygmont Chester Stanley III(Chief Financial Officer)	A	$70K
2025-02-11	Zygmont Chester Stanley III(Chief Financial Officer)	A	$58K
2026-01-08	Chawla Lakhmir S	A	$38K
2026-01-08	ROPER JESS	A	$38K
2026-01-08	CARVER JENNIFER	A	$38K
2026-02-04	Zygmont Chester Stanley III(Chief Financial Officer)	F	$22K
2025-10-29	ROPER JESS	A	$20K
2025-10-29	CARVER JENNIFER	A	$20K
2025-10-29	Chawla Lakhmir S	A	$20K
2026-02-03	Rolke James(Chief Executive Officer)	F	$16K
2026-04-30	Zygmont Chester Stanley III(Chief Financial Officer)	F	$15K
2026-04-30	Rolke James(Chief Executive Officer)	F	$11K
2026-02-03	Chawla Lakhmir S	F	$4K
2026-02-03	CARVER JENNIFER	F	$3K
2026-02-03	ROPER JESS	F	$3K
2025-02-11	TIDMARSH GEORGE F	A	$700.47

Legal entity: GLEIF

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

REVELATION BIOSCIENCES, INC. — Contributions, Lobbying & Contracts | Poliscope